Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with99mTc using aminocarboxylates as coligands

Bioconjugate Chemistry

Volumn 7, Issue 1, 1996, Pages 63-71

  Liu, Shuang ^a   Scott Edwards, D ^a   Looby, Richard J ^a   Harris, Anthony R ^a   Poirier, Michael J ^a   Barrett, John A ^a   Heminway, Stuart J ^a   Carroll, Timothy R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE COMPOUNDS; CHROMATOGRAPHIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMERS; NITROGEN COMPOUNDS; SYNTHESIS (CHEMICAL);

6-AMINOCAPROIC ACID; AMINO-CARBOXYLATES; CO-LIGANDS; LABELINGS; MULTIPLE SPECIES; PERTECHNETATE; RADIOLABELLING; REACTION MIXTURE; RECEPTOR ANTAGONISTS; SYNTHESISED;

MIXTURES;

THROMBUS;

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FIBRINOGEN RECEPTOR; LIGAND; NICOTINAMIDE; TECHNETIUM; TECHNETIUM COMPLEX;

AMINO ACID SEQUENCE; ARTICLE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; METABOLISM; MOLECULAR GENETICS; RADIOASSAY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; INDICATORS AND REAGENTS; KINETICS; LIGANDS; MOLECULAR SEQUENCE DATA; NIACINAMIDE; ORGANOTECHNETIUM COMPOUNDS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RADIOLIGAND ASSAY; STRUCTURE-ACTIVITY RELATIONSHIP; TECHNETIUM;

EID: 0029685434     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc950069+     Document Type: Article

References (39)

1. Goldenberg, D. M. (1989) Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy. Seminars Nucl. Med. 19, 332-339.
2. Eckelman, W. C. (1994) The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals. Nucl. Med. Biol. 21, 759-769.
3. Fischman, A. J., Babich, J. W ., and Strauss, H. W. (1993) A ticket to ride: peptide radiophamaceuticals. J. Nucl. Med. 34. 2253-2263.
4. Fischman, A. J., Babich, J. W ., and Rubin, H. R. (1993) Infection imaging with technetium-99m-labeled chemotactic peptides analog. Semin. Nucl. Med. 24, 154-168.
5. 99Tc. Nucl. Med. Biol. 16, 171-176.
6. Fritzberg, A. R., Berninger, R W., Hadley, S. W ., and Wester, D. W. (1988) Approaches to radiolabeling of antibodies for diagnosis and therapv of cancer. Pharm. Res. 5, 325-334.
7. Otsuka, F. L ., and Welch, M. J. (1987) Methods to label monoclonal antibodies for use in tumor imaging. Nucl. Med. Biol. 14, 243-249.
8. Hnatowich, D. J. (1990) Antibody radiolabeling, problems and promises. Nucl. Med. Biol. 17, 49-55.
9. Hnatowich, D. J. (1990) Recent developments in radiolabeling of antibodies with iodine, indium, and technetium. Semin. Nucl. Med. 20, 80-91.
10. Srivastava, S. C ., and Mease, R. C. (1991) Progress in research on ligands, nuculides and techniques for labeling monoclonal antibodies. Nucl. Med. Biol. 18. 589-603.
11. Barrett, J. A., Heminway, S. J., Damphousse, D. J., Thomas, J. R; Looby, R J., Edwards, D S., Harris, T. D., Rajopadhye, M., Liu, S ., and Carroll, T. R (1994) Platelet GP IIb/IIIa antagonists in the canine arteriovenous shunt: potential thrombus imaging agents. J. Nucl. Med. 35, 52P (Abstract 202).
12. Harris, T. D., Barrett, J. A., Bourque, J. P., Carroll, T. R., Damphousse, P. R., Edwarde, D. S., Glowacka, D., Liu, S., Leoby. R. J., Poirier, M. J., Rajopadhye, M ., and Yu, K.(1994) Design and synthesis of radiolabeled GPIIb/IIIa receptor antagonists as potential thrombus imaging agents. J. Nucl. Med. 35, 245P (Abstract 1005).
13. Barrett, J. A., Bresnick, M., Crocker, A., Damphousse, D. J., Hampson, J. R., Heminway, S. J., Mazaika, T. J., Kagan, M., Lazewatsky, J., Edwards, D. S., Liu, S., Harris, T. D., Rajopadhye, M ., and Carroll, T. R. (1995) RP-431: a potential thrombus imaging agent. J. Nucl. Med. 36, 16P (Abstract 55).
14. 99mTc-protein conjugate. Bioconjugate Chem. 2, 334-336.
15. Abrams. M. J., Juweid, M., tenKate, C. I., Schwartz, D. A., Hauser, M. M., Gaul, F. E., Fuccello, A. J., Rubin, R. H., Strauss. H. W ., and Fischman, A. J. (1990) Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 31, 2022-2028.
16. Babich, J. W., Solomon, H., Pike, M. C., Kroon, D., Graham, W., Abrams, M. J., Tompkins, R. G., Rubin, R. H ., and Fischman, A. J. (1993) Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. J. Nucl. Med. 34, 1967-1974.
17. 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides. Nucl. Med. Biol. 22, 25-30.
18. 99mTc labeling of hydrazino nicotinamide modified human polyclonal IgG. J. Nucl. Med. 35, 105P.
19. 99mTc labeling of hydrazino nicotinamide modified proteins. J. Labeled Compds. Radiopharm, 35, 1-2.
20. Rajopadhye, M., Edwards, D. S ., and Liu, S. Unpublished data.
21. Lanteingne, D ., and and to Hnatowich, D. J. (1984) The labeling of DTPA coupled proteins. Int. J. Radiat. Isot. 35, 617-621.
22. Kasina, S., Rao, T. N., Srinivasan, A., Sanderson, J. A., Fitner, J. N., Reno, J. M., Beaunier, P. L ., and Fritzberg, A. R. (1991) Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent, J. Nucl. Med. 32. 1445-1451.
23. Fritzberg, A. R., Abrams, P. G., Beaumier, P. L., Kasina, S., Morgan, A. C., Rao, T. N., Reno, J. M., Sanderson, J. A., Srinivasan, A ., and Wilbur, D. S. (1988) Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proc. Natl. Acad. Sci. U.S.A. 85, 4025-4029.
24. 99mTc. In Technetium and Rhenium in Chemistry and Nuclear Medicine (M. Nicolini, G. Bandoli, and U. Mazzi, Eds.), pp 383-393, SGEditoriali, Padova.
25. 3 PITC. Bioconjugate Chem. 2, 160-170.
26. 2- Bioconjugate Chem. 2, 4O7-414.
27. Baidoo, K. E., Scheffel, U., Finley, P ., and Lever, S. Z. (1994) No carrier added (NCA)7 Tc-99m-diaminedithiolate derivatives of chemotactic peptides for imaging inflammation. J. Nucl. Med. 35, 19P (Abstract 67).
28. Jackson, S., DeGrado, W., Dwivdi, A., Parthasarathy, A., Hifley. A., Krywko, J., Rockwell, A, Markwalder, J., Wells, G., Wexler, R., Mousa, S ., and Harlow R. (1994) Template-canstrained cyclic peptides: design of high-affinity ligands for GP IIb/IIIa. J. Am. Chem. Soc. 116, 3220-3230.
29. Archer, C. M., Dilworth, J. R., Jobanputra, P., Thompson, R. M., McPartlin, M., Povey, D. C., Smith, G. W ., and Kelly, J. D. (1990) Development of new technetium cores containing technetium-nitrogen multiple bonds, Synthesis and characterization of some diazenido-, hydrazido- and imido- complexaa of technetium. Polyhedron 9, 1497-1502.
30. 3)]. Z. Naturforsch. 46, 449-452.
31. 2O. J. Chem. Soc., Dalton Trans., 897-904.
32. 4]. J. Chem. Soc., Dolton Trans., 1251-1256.
33. 2. Inorg. Chim. Acta 185, 7-15.
34. Plow, E. F., Margueri,. G ., and Ginsberg. M. (1987) Fibrinogen, fibriogen receptors and the peptides that inhibit these interactions. Biochem. Pharmacol. 36, 4035-4041.
35. *2 bond. Inorg. Chem. 20, 3829-3834.
36. 2O. Inorg. Chem. 28, 3820-3825.
37. 99mTc-labeled radiopharmaceoticals. Semin. Nucl. Med. 20, 5-7.
38. Amos, L. W ., and Sawyer, D. T. (1972) Proton nuclear magnetic resonance studies of several polyaminocarboxylic acid complexes of vanadium(V). Inorg. Chem, 11, 2692-2697.
39. Crans, D. C ., and Shin, P. K. (1994) Characterization of vanadium(V) complexes in aqueous solutions: ethanolaminesnd glycine-derived complexes. J. Am. Chem. Soc. 116, 1305-1315.